Oct
2026
Fiera Milano, Italy
Visit us
stand 18G77, Finished Dosage & Formulation
Zone

LISAPHARMA

Exhibitor at CPHI Milan 2026
About Us

Lisapharma is an Italian pharmaceutical company specialized in the production and development of sterile injectable drugs (powders in vials, liquid forms in amps and vials), non-sterile liquids, semi-solid and MDs. Lisapharma operates as CMO partner for Italian and International Companies, providing its know-how of finished dosage forms for human and veterinary use, fully GMP, FDA approved. Lisapharma operates in the Italian and international markets through a portfolio of registered proprietary medicines, dealing with about 80 international customers active on marketing.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 18G77, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • LISATHYONE

    Product LISATHYONE

    ACTIVE PRINCIPLE INGREDIENT: glutathione sodium salt   INDICATONS: prophylaxis of neuropathies following chemoterapy with cisplatin or cisplatin analogues PHARMACEUTICAL FORM - DOSAGE: Powder and solution for injection 600mg/3ml IM - IV PACKAGE: 1 powder vial + 1 solv. ampoule  ...
  • LISAMETHYLE

    Product LISAMETHYLE

    ACTIVE PRINCIPLE INGREDIENT: Methylprednisolone sodium succinate INDICATIONS: Corticosteroid,  anti-inflammatory drug PHARMACEUTICAL FORM - DOSAGE:  20mg/2ml; 40mg/2ml; 120mg/2ml powder and solvent for solution for injection injection IM - IV;  500mg powder for solution for inj...
  • ARFEN

    Product ARFEN

    ACTIVE PRINCIPLE INGREDIENT: ibuprofen lysinate. INDICATIONS: NSAID. Chronic symptomatic treatment of rheumatoid arthritis and osteoarthritis.  PHARMACEUTICAL FORM - DOSAGE: injectable ampoules 3ml - 600mg    PACKAGE: 6 vials/box
  • SUCRATE GEL

    Product SUCRATE GEL

    ACTIVE PRINCIPLE INGREDIENT: Sucralfate gel.INDICATIONS: Gastric ulcer, duodenal ulcer, acute gastritis, symptomatic chronic gastritis, NSAID-related gastric pathologies, reflux esophagitis. PHARMACEUTICAL FORM - DOSAGE - PACKAGE: oral sachets   1g/5ml, 30 sachets/box  -   2...
  • LIKACIN

    Product LIKACIN

    ACTIVE PRINCIPLE INGREDIENT: Amikacin sulfate.INDICATIONS: Semi-synthetic aminoglycoside antibiotic with broad anti- gram positive/gram- negative spectrum.   PHARMACEUTICAL FORM - DOSAGE - PACKAGING: 1 vial 250mg/2ml IM-IV, 1 vial 500mg/2ml IM-IV, 1 vial 1g/4ml IM-IV.  1 vial 250mg/2ml IM...